{"id":"W3159120388","doi":"10.1158/1078-0432.ccr-20-4259","title":"Veliparib in Combination with Carboplatin and Etoposide in Patients with Treatment-Naïve Extensive-Stage Small Cell Lung Cancer: A Phase 2 Randomized Study","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"ca_institutions":"Juravinski Cancer Centre","funders":"","keywords":"Veliparib; Medicine; Carboplatin; Internal medicine; Hazard ratio; Etoposide; Placebo; Oncology; Lung cancer; Chemotherapy; Clinical endpoint; Surgery; Confidence interval; Clinical trial; Pathology; Cisplatin; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002390265,0.001417471,0.002881957,0.0003584488,0.0004236492,0.001201886,0.001005994,0.001357331,0.004012949],"category_scores_gemma":[0.00126006,0.0009029334,0.001773255,0.000498964,0.001040939,0.0009927006,0.0004339253,0.002736018,0.0006160813],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008437225,"about_ca_system_score_gemma":0.001706152,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006626605,"about_ca_topic_score_gemma":0.001986493,"domain_scores_codex":[0.9991228,0.0005291294,0.00005286611,0.0001307993,0.00006428809,0.0001000641],"domain_scores_gemma":[0.9991354,0.0002120586,0.0002093042,0.00007262053,0.000052099,0.00031856],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9232209,0.03683717,0.002805311,0.0006663062,0.001379882,0.0001101189,0.0000775432,0.0006556709,0.007182662,0.00007749329,0.0007145144,0.02627253],"study_design_scores_gemma":[0.8690756,0.1267062,0.002513133,0.00001911025,0.0003972303,0.00005987925,0.00001634326,0.0003301992,0.0003102933,0.00005100677,0.0005099478,0.0000109879],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9917741,0.002885946,0.0004504548,0.0003751342,0.0001753165,0.003102187,0.0004257465,0.00004786954,0.0007632206],"genre_scores_gemma":[0.9894997,0.002599267,0.001329408,0.0008966565,0.0004153413,0.003202953,0.0008444752,0.00001653629,0.001195623],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004012949,"threshold_uncertainty_score":0.01342463,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1115676410320947,"score_gpt":0.509988089102433,"score_spread":0.3984204480703383,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}